SCHEMBL1236716

SCHEMBL1236716

CC(C)(c1cc(O)c2cc(-c3ccccc3)oc2c1)C1CCCCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.41
KDM4E B2RXH2 3/20 0.41
TP53 P04637 3/20 0.41
HSD17B10 Q99714 3/20 0.41
ALOX15 P16050 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
CYP19A1 P11511 2/20 0.41
HPGD P15428 2/20 0.41
ALOX12 P18054 2/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
ALDH1A1 P00352 3/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C19 P33261 2/20 0.39
FTO Q9C0B1 4/20 0.38
CYP1A2 P05177 4/20 0.38
CYP1B1 Q16678 4/20 0.38
PKM P14618 3/20 0.38
ABCB1 P08183 3/20 0.38
CALM1 P0DP23 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1234602 0.85 SIRT1 (0.37) CNR1CNR2SIRT1
SCHEMBL1236725 0.78 CNR1 (0.49) MAPTKDM4ETP53HSD17B10ALOX15
SCHEMBL1236809 0.75 ALDH1A1 (0.43) MAPTKDM4ETP53HSD17B10ALOX15
SCHEMBL28643746 0.70 SIRT1 (0.67) MAPTKDM4ETP53HSD17B10ALOX15
SCHEMBL846064 0.68 KEAP1 (0.48) MAPTCYP2D6CYP3A4BLML3MBTL1
SCHEMBL24539680 0.67 HPGD (0.44) MAPTKDM4ETP53HSD17B10SMN1; SMN2
SCHEMBL10995009 0.66 KEAP1 (0.50) CYP2D6CYP3A4L3MBTL1
SCHEMBL27906906 0.65 MAPT (0.63) MAPTKDM4ETP53HSD17B10ALOX15
SCHEMBL1039351 0.65 GABRA1 (0.41) HSD17B10HPGDALDH1A1CYP2D6CYP2C19
SCHEMBL1039185 0.65 GABRA1 (0.41) HSD17B10HPGDALDH1A1CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8476309-B2 Benzofuran cannabinoid compounds and related methods of use THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) 2013-07-02 US claimed
US-20110046175-A1 BENZOFURAN CANNABINOID COMPOUNDS AND RELATED METHODS OF USE THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2011-02-24 US claimed
WO-2011022679-A2 BENZOFURAN CANNABINOID COMPOUNDS AND RELATED METHODS OF USE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, THE (US) 2011-02-24 WO claimed
US-8476309-B2 Benzofuran cannabinoid compounds and related methods of use THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) 2013-07-02 US disclosed
US-8476309-B2 Benzofuran cannabinoid compounds and related methods of use THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) 2013-07-02 US disclosed
US-8476309-B2 Benzofuran cannabinoid compounds and related methods of use THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) 2013-07-02 US disclosed
US-20110046175-A1 BENZOFURAN CANNABINOID COMPOUNDS AND RELATED METHODS OF USE THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2011-02-24 US disclosed
US-20110046175-A1 BENZOFURAN CANNABINOID COMPOUNDS AND RELATED METHODS OF USE THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2011-02-24 US disclosed
US-20110046175-A1 BENZOFURAN CANNABINOID COMPOUNDS AND RELATED METHODS OF USE THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION 2011-02-24 US disclosed
WO-2011022679-A2 BENZOFURAN CANNABINOID COMPOUNDS AND RELATED METHODS OF USE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, THE (US) 2011-02-24 WO disclosed
WO-2011022679-A2 BENZOFURAN CANNABINOID COMPOUNDS AND RELATED METHODS OF USE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION, THE (US) 2011-02-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110046175-A1 BENZOFURAN CANNABINOID COMPOUNDS AND RELATED METHODS OF USE CNR1, CNR2, GPR18 MAPT 4143/4885KDM4E 2379/4885TP53 4847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.